Effectiveness of bortezomib and temozolomide for eradication of recurrent human glioblastoma cells, resistant to radiation

替莫唑胺 癌症研究 放化疗 医学 肿瘤科 小桶 抗辐射性 达卡巴嗪 胶质母细胞瘤 化疗 内科学 放射治疗 生物 基因 转录组 生物化学 基因表达
作者
Oleg Pak,Sergei Zaitsev,В. Е. Шевченко,Aruna Sharma,Hari Shanker Sharma,Igor Bryukhovetskiy
出处
期刊:Progress in Brain Research [Elsevier BV]
卷期号:28 (1): 195-209 被引量:9
标识
DOI:10.1016/bs.pbr.2021.06.010
摘要

Glioblastoma multiforme (GBM) is a primary human brain tumor with the highest mortality rate. The prognosis for such patients is unfavorable, since the tumor is highly resistant to treatment, and the median survival of patients is 13 months. Chemotherapy might extend patients' life, but a tumor, that reappears after chemoradiotherapy, is resistant to temozolomide (TMZ). Using postgenome technologies in clinical practice might have a positive effect on the treatment of a recurrent GBM.T98G cells of human GBM have been used. Radiation treatment was performed with Rokus-M gamma-therapeutic system, using 60Сo as a source of radionuclide emissions. High-performance liquid chromatography-mass spectrometry was used for proteome analysis. Mass spectrometry data were processed with MaxQuant (version 1.6.1.0) and Perseus (version 1.6.1) software, Max Planck Institute of Biochemistry (Germany). Biological processes, molecular functions, cells locations and protein pathways were annotated with a help of PubMed, PANTHER, Gene Ontology and KEGG and STRING v10 databases. Pharmaceutical testing was performed in vitro with a panel of traditional chemotherapeutic agents.GBM cells proliferation speed is inversely proportional to the irradiation dose and recedes when the dosage is increased, as expected. Synthesis of ERC1, NARG1L, PLCD3, ROCK2, SARNP, TMSB4X and YTHDF2 in GBM cells, treated with 60Gy of radiation, shows more than a fourfold increase, while the synthesis level of PSMA2, PSMA3, PSMA4, PSMB2, PSMB3, PSMB7, PSMC3, PSMD1, PSMD3 proteins increases significantly. Traditional chemotherapeutic agents are not very effective against cancer cells of the recurrent GBM. Combination of TMZ and CCNU with a proteasome inhibitor-bortezomib-significantly increases their ability to eradicate cells of a radioresistant GBM.Bortezomib and temozolomide effectively destroy cells of a radioresistant recurrent human glioblastoma; proteome mapping of the recurrent GBM cancer cells allows to identify new targets for therapy to improve the treatment results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
adaniu发布了新的文献求助10
1秒前
啦啦啦完成签到,获得积分10
1秒前
1秒前
威alisa发布了新的文献求助10
1秒前
欣喜的澜发布了新的文献求助10
2秒前
WJF发布了新的文献求助10
2秒前
李爱国的应助被123采纳,获得10
2秒前
鸡翅完成签到,获得积分10
2秒前
2秒前
3秒前
molihuakai的应助被懒洋洋采纳,获得10
3秒前
3秒前
852的应助被nihao采纳,获得10
3秒前
3秒前
刘承昭发布了新的文献求助10
3秒前
1qq发布了新的文献求助10
3秒前
bkagyin的应助被Xiaoab采纳,获得10
4秒前
青竹发布了新的文献求助10
4秒前
4秒前
lclc完成签到 ,获得积分10
4秒前
MexMexMex完成签到,获得积分10
4秒前
cai发布了新的文献求助10
5秒前
笨笨是研究生完成签到,获得积分10
5秒前
正念发布了新的文献求助10
5秒前
SSDlk完成签到,获得积分10
5秒前
5秒前
5秒前
顾矜的应助被舒适平文采纳,获得10
5秒前
We1irdo完成签到,获得积分10
5秒前
5秒前
俞凡白完成签到,获得积分10
6秒前
flint发布了新的文献求助10
6秒前
徐自谦发布了新的文献求助10
6秒前
Leo完成签到,获得积分10
7秒前
zhhyi1976完成签到,获得积分10
7秒前
WWanT完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162138
求助须知:如何正确求助?哪些是违规求助? 9556501
关于积分的说明 21735379
捐赠科研通 7752349
什么是DOI,文献DOI怎么找? 3427639
关于科研通互助平台的介绍 2552678
邀请新用户注册赠送积分活动 2472242